Literature DB >> 21539858

Dextran-g-PEI nanoparticles as a carrier for co-delivery of adriamycin and plasmid into osteosarcoma cells.

Kuo Sun1, Jing Wang, Jian Zhang, Min Hua, Changsheng Liu, Tongyi Chen.   

Abstract

Combination of chemotherapy and gene therapy of pan class="Disease">cancer has synergistic effects on overcoming drug resistance. Macromolecular materials such as n>an class="Chemical">dextran and PEI have been a potential module for chemotherapeutics and gene delivery. Herein, we hypothesize the combinational strategy of chemotherapy and gene therapy in a single dextran-PEI nanoplatform. The physicochemical properties, cytotoxicity, transfection efficiency were investigated in vitro. Ultra-violet spectrum and (1)H NMR revealed adriamycin and PEI were grafted to dextran chain. Agarose gel electrophoresis demonstrated that the migration of plasmid was completely retarded when the N/P ratio of complex was 4. The sizes of DEX-ADM-PEI/DNA nanoparticles decreased and the zeta potentials enhanced with the increasing N/P ratio. Transmission electron microscope indicated a round morphology of the nanoparticles. DEX-ADM-PEI conjugation has higher cytotoxicity, compared to free adriamycin, in MG-63 and Saos-2 osteosarcoma cells but DEX-PEI maintained over 65% cell viability at the concentration of 8 mg/mL. The transfection efficiency of DEX-ADM-PEI/pEGFP-N1 at N/P ratio of 4:1 both in MG-63 and Saos-2 cell were slightly low than that of PEI 25k. But our nanoplatform efficiently delivered both plasmid pEGFP-N1 and adriamycin into osteosarcoma cells. This study demonstrated that DEX-ADM-PEI efficiently and selectively delivered both plasmid pEGFP-N1 and adriamycin to osteosarcoma cells with low cytotoxicity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21539858     DOI: 10.1016/j.ijbiomac.2011.04.007

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

Review 1.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

2.  Polyethylenimine functionalized magnetic nanoparticles as a potential non-viral vector for gene delivery.

Authors:  Yangbo Zhou; Zhaomin Tang; Chunli Shi; Shuai Shi; Zhiyong Qian; Shaobing Zhou
Journal:  J Mater Sci Mater Med       Date:  2012-07-24       Impact factor: 3.896

3.  Insight into the role of N,N-dimethylaminoethyl methacrylate (DMAEMA) conjugation onto poly(ethylenimine): cell viability and gene transfection studies.

Authors:  Alireza Nouri; Rita Castro; Visvaldas Kairys; José L Santos; João Rodrigues; Yulin Li; Helena Tomás
Journal:  J Mater Sci Mater Med       Date:  2012-09-04       Impact factor: 3.896

Review 4.  Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration.

Authors:  Wenyi Gu; Chengtie Wu; Jiezhong Chen; Yin Xiao
Journal:  Int J Nanomedicine       Date:  2013-06-25

5.  Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells.

Authors:  Linlin Zhang; Arun K Lyer; Xiaoqian Yang; Eisuke Kobayashi; Yuqi Guo; Henry Mankin; Francis J Hornicek; Mansoor M Amiji; Zhenfeng Duan
Journal:  Int J Nanomedicine       Date:  2015-04-15

Review 6.  Modified Nanoparticles as Potential Agents in Bone Diseases: Cancer and Implant-Related Complications.

Authors:  Karol P Steckiewicz; Iwona Inkielewicz-Stepniak
Journal:  Nanomaterials (Basel)       Date:  2020-04-01       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.